590 related articles for article (PubMed ID: 24078988)
1. Aflatoxins as a cause of hepatocellular carcinoma.
Kew MC
J Gastrointestin Liver Dis; 2013 Sep; 22(3):305-10. PubMed ID: 24078988
[TBL] [Abstract][Full Text] [Related]
2. The association between exposure to aflatoxin, mutation in TP53, infection with hepatitis B virus, and occurrence of liver disease in a selected population in Hyderabad, India.
Anitha S; Raghunadharao D; Waliyar F; Sudini H; Parveen M; Rao R; Kumar PL
Mutat Res Genet Toxicol Environ Mutagen; 2014 May; 766():23-8. PubMed ID: 24657665
[TBL] [Abstract][Full Text] [Related]
3. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
[TBL] [Abstract][Full Text] [Related]
4. [Aflatoxins: current concepts on mechanisms of toxicity and their involvement in the etiology of hepatocellular carcinoma].
de Oliveira CA; Germano PM
Rev Saude Publica; 1997 Aug; 31(4):417-24. PubMed ID: 9595771
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma: from gene to public health.
Montesano R; Hainaut P; Wild CP
J Natl Cancer Inst; 1997 Dec; 89(24):1844-51. PubMed ID: 9414172
[TBL] [Abstract][Full Text] [Related]
6. Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review.
Wogan GN; Kensler TW; Groopman JD
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2012; 29(2):249-57. PubMed ID: 21623489
[TBL] [Abstract][Full Text] [Related]
7. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms underlying aflatoxin-associated mutagenesis - Implications in carcinogenesis.
McCullough AK; Lloyd RS
DNA Repair (Amst); 2019 May; 77():76-86. PubMed ID: 30897375
[TBL] [Abstract][Full Text] [Related]
9. [Aflatoxins--health risk factors].
Miliţă NM; Mihăescu G; Chifiriuc C
Bacteriol Virusol Parazitol Epidemiol; 2010; 55(1):19-24. PubMed ID: 21038701
[TBL] [Abstract][Full Text] [Related]
10. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
11. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.
Bressac B; Kew M; Wands J; Ozturk M
Nature; 1991 Apr; 350(6317):429-31. PubMed ID: 1672732
[TBL] [Abstract][Full Text] [Related]
12. Aflatoxins, hepatocellular carcinoma and public health.
Magnussen A; Parsi MA
World J Gastroenterol; 2013 Mar; 19(10):1508-12. PubMed ID: 23539499
[TBL] [Abstract][Full Text] [Related]
13. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan.
Yu MW; Lien JP; Chiu YH; Santella RM; Liaw YF; Chen CJ
J Hepatol; 1997 Aug; 27(2):320-30. PubMed ID: 9288607
[TBL] [Abstract][Full Text] [Related]
14. [p53 and hepatocellular carcinomas].
Mihm S; Leonhardt U; Ramadori G
Z Gastroenterol; 1993 Sep; 31(9):498-9. PubMed ID: 8237091
[No Abstract] [Full Text] [Related]
15. Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma.
El-Shanawani FM; Abdel-Hadi AA; Abu Zikri NB; Ismail A; El-Ansary M; El-Raai A
J Egypt Soc Parasitol; 2006 Apr; 36(1):221-39. PubMed ID: 16605112
[TBL] [Abstract][Full Text] [Related]
16. Aflatoxins as risk factors for hepatocellular carcinoma in humans.
Wogan GN
Cancer Res; 1992 Apr; 52(7 Suppl):2114s-2118s. PubMed ID: 1311989
[TBL] [Abstract][Full Text] [Related]
17. A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention.
Wild CP; Montesano R
Cancer Lett; 2009 Dec; 286(1):22-8. PubMed ID: 19345001
[TBL] [Abstract][Full Text] [Related]
18. Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo.
Swenson DH; Lin JK; Miller EC; Miller JA
Cancer Res; 1977 Jan; 37(1):172-81. PubMed ID: 187331
[TBL] [Abstract][Full Text] [Related]
19. Interactive effects of chemical carcinogens and hepatitis B virus in the pathogenesis of hepatocellular carcinoma.
Harris CC; Sun TT
Cancer Surv; 1986; 5(4):765-80. PubMed ID: 3040243
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome profiling of malignant transformed rat hepatic stem-like cells by aflatoxin B1.
Yang L; Ji J; Chen Z; Wang H; Li J
Neoplasma; 2014; 61(2):193-204. PubMed ID: 24299315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
